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Background: Mechanisms of acquired protection to malaria in asymptomatic Plasmodium falciparum carriers are
only partially understood. Among them, the role plays by the self-reactive antibodies has not been clarified yet. In
this study, the relationship between repertoires of circulating self-reactive and parasite-specific immunoglobulin G
(IgG), their correlation with cytokine levels, and their association with protection against malaria was investigated in
asymptomatic Plasmodium falciparum-infected Gabonese children.
Methods: The diversity of P. falciparum-specific antibody repertoire was analysed using a protein micro-array
immunoassay, the total auto-antibody repertoire by quantitative immunoblotting and circulating cytokine levels
were measured by ELISA in endemic controls (EC) and P. falciparum-infected children from Gabon with asymptomatic
(AM) or mild malaria (MM). The association of self- and parasite-specific antibody repertoires with circulating cytokines
was evaluated using single linkage hierarchical clustering, Kruskal – Wallis tests and Spearman’s rank correlation.
Results: Children with AM exhibited an IgG response to merozoite surface protein 3 (MSP3) but not to MSP1-19,
although their levels of total P. falciparum-specific IgG were similar to those in the MM group. Moreover, the
asymptomatic children had increased levels of autoantibodies recognising brain antigens. In addition, a correlation
between IL-10 levels and parasite load was found in AM and MM children. These two groups also exhibited significant
correlations between plasma levels of IL-10 and IFN-γ with age and with total plasma IgG levels. IL-10 and IFN-γ levels
were also associated with auto-antibody responses in AM.
Conclusions: Altogether, these results indicate that a self-reactive polyclonal response associated with increased IgG
to MSP3 and high plasma levels of IL-10 and IFN-γ may contribute to protective immune mechanisms triggered in
asymptomatic P. falciparum infection in Gabonese children.
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Plasmodium falciparum infection can lead to asymptom-
atic malaria (AM), mild malaria (MM) or severe malaria
(SM) [1]. Despite considerable research, the mechanisms
of naturally acquired immunity to malaria are only
partially understood. Natural protection against malaria is
acquired after years of continuous exposure to infectious
mosquito bites [2], and such clinical immunity is multifac-
torial. Besides a cellular response, antibody-mediated
effector mechanisms are implicated in protective immunity
[3-5]. However, this protection is against severe disease, not
re-infection. Clearly, long-term immunity to malaria is
characterized by the ability to reduce, but not eliminate, the
parasite load and, therefore, to better tolerate disease − the
‘premunition’ defined by Sergent [2]. There is still a
need to identify immune response components of clinical
immunity.
Malaria is associated with hypergammaglobulinemia and
the production of self-reactive antibodies that recognize
self-antigens, such as phospholipid, cardiolipin, ssDNA,
dsDNA, and rheumatoid factor [6-9], although they
may also recognize parasite antigens. However, whether
these self-reactive antibodies play a role in protection
against parasite infection or severe disease is unclear.
It is thus of critical importance to quantitatively
study the range of antibody reactivities to understand
the complexity of the humoral immune response to
P. falciparum.
Several mechanisms may contribute to auto-antibody
production in malaria. These include polyclonal B cell
activation by parasitic mitogens [8], stimulation of B
cells by molecular mimicry [10,11], dysregulation of B
cell functions [12], and stimulation of B cells involved in
auto-antibody production [13]. An integrated approach
has been implemented in an endemic area of Libreville
in Gabon to study the diversity of auto-antibody and
parasite-specific repertoires in P. falciparum-infected
children with either AM or MM and in healthy children
(endemic control (EC)). The global analysis of antibody
repertoires was done using a microarray immunoassay
[14] and quantitative auto-antibody immunoblots [15-18]
coupled to bio-informatics and statistics. For insights into
the regulatory factors involved, the association of antibody
repertoires with circulating cytokine patterns was also
investigated in AM or MM and EC from an endemic
area of Libreville, Gabon.
Results clearly show that IgG autoreactivity was greater
in AM than in MM children. In addition, the auto-antibody
response was correlated significantly with the presence of
anti-merozoite surface protein antigen 3 (MSP3) IgG and
high levels of IL-10 in the AM group. By contrast,
anti-MSP1 IgG was predominant in MM patients.
Interestingly, IL-10 levels were also associated with
parasite load in AM and MM groups.Altogether, these results strongly support a protective
role for auto-antibodies triggered by the parasite which
correlate with plasma IL-10 levels and with anti-MSP2
and anti-MSP3 IgG levels in clinical immunity observed
in asymptomatic P. falciparum carriers.
Methods
Study population
The ethics committee of the Gabon Health Office
approved this study. Between 1996 and 2000, 97 children
(age range two months to six years) living in Libreville
Hospital Centre (Gabon) were included in the study after
obtaining parental informed consent. All patients present-
ing diseases other than malaria were excluded from the
study. Malaria patients were categorized on the basis of
World Health Organization (WHO) guidelines for the
definition of uncomplicated malaria. Mild malaria (MM)
presented fever with positive thin blood smears. Individuals
with positive P. falciparum thin blood smears and no
clinical symptoms were included in the asymptomatic
malaria (AM) group and were defined as AM carriers and
children with no clinical symptoms and a negative thin
blood smears were enrolled in the endemic control (EC)
group. All AM and EC children were from the same area
of Libreville city. MM were recruited at Owendo Pediatric
Hospital (OPH) and Libreville Hospital Centre. AM
and EC children were examined daily for clinical
symptoms. Parasitaemia were determined on days 0
(day of hospitalization), 7 and 30. Oral amodiaquine
(25 mg/kg) was administered for three days from day-0 to
MM patients and at day 30 to AM carriers. No patient
death occurred during the recruitment period.
Blood sample collection and parasite assessment
Venous blood was collected in EDTA on days 0 (before
treatment), 7 and 30. Plasma was separated and stored
at −80°C until use. Parasitaemia (expressed as the
percentage of infected erythrocytes) was determined
by microscopic examination of Giemsa-stained thin
blood smears.
Cytokine assays
Plasmatic levels of IFN-γ, TNF and IL-10 were measured
in EC, AM and MM at day 0, 7 and 30 using a
sandwich-type ELISA (Kit OptEIA set, Pharmingen, BD
Bioscience, France) according to the manufacturer’s
recommendations.
Determination of plasmatic levels of total
immunoglobulin G
The quantification of total IgG in children plasma from
all groups was done by ELISA. At day 0, 7 and 30 after
their inclusion in the study. Briefly, 96 microwell plates
(reacti-bind 96 EIA Plate 100/PKG, Pierce) were coated
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IgG (Sigma-Aldrich, France) followed by overnight
incubation at 4°C. After blockage with 1% gelatine
and washing with 1% gelatin-PBS, serial dilutions of
plasma samples were incubated overnight at 4°C. Bound
IgG was detected using a peroxidase-conjugated polyclonal
anti-human-IgG (The Binding Site, Birmingham UK). Bind-
ing was revealed using 0.5 mg/ml O-phenylenediamine
(OPD) substrate (Sigma-Aldrich, France) and 0.03% H2O2
in 0.05 M phosphate-citrate buffer, pH5 and the product
was quantified from the optical density (OD) at 450 nm.
The mean of OD value was fitted into the sigmoidal
standard curve using a specific ELISA programme running
in Igor version 3.16 (Wavemetrics, Lake Oswego, OR).
Total Plasmodium falciparum-specific immunoglobulin
G quantification
Total P. falciparum specific plasmatic IgGs were quantified
using ELISA. Briefly, ninety-six-well plates (Reacti-Bind 96
EIA Plat Corn Not, Pierce) were coated overnight at 4°C
with 5 μg/ml of P. falciparum 3D7 schizont-stage protein
extract. Plates were blocked with 1% gelatine. One-
hundred ml of 1:100 dilution of patient plasma was added
to each well in duplicate, incubated for one hour at 37°C,
and developed using anti-human IgG-HRP and OPD
(Sigma-Aldrich, France). Ten per cent sodium dodecyl
sulphate was added after 30 min and the OD measured at
450 nm. Concentration of P. falciparum-specific IgG
in the samples was calculated from a standard curve
using 0.001 − 2 mg/ml of purified human IgG. For every
sample tested a cut-off value was estimated using a pool
of plasma from children living in Europe who had never
been exposed to P. falciparum infection.
Determination of Plasmodium falciparum-specific
antibody repertoire
The plasma parasite-specific antibodies were profiled
using a protein micro-array immuno-assay [14]. Each
array contained 20 recombinant antigens derived from
leading blood-stage vaccine candidates, including antigenic
variants of MSP1, MSP2 and MSP3, apical membrane
antigen 1 (AMA1), P. falciparum erythrocyte membrane
protein 1 (PfEMP1), and circumsporozoite protein epitope
NANP-4. Arrays were incubated with 100 μl of 1:100 dilu-
tion of plasma for 15 min at 37°C and washed for 5 min in
PBS-Tween. Arrays were then incubated with Alexa Fluor
546-labelled anti-human IgG monoclonal antibody (1:1,000;
Jackson Immunoresearch Europe, UK) for 20 min.
Alexa 555 diluted 1:1 in PBS was used as signal con-
trol. Ten mg/ml bovine serum albumin was used as a
negative control. Anti-human IgG (Sigma, France) was
used as carry-over control. Arrays were washed twice in
PBS-Tween, dried under nitrogen, and scanned with a
GMS 428 scanner (Affymetrix, Santa Clara, CA, USA).Acquired images were analysed with the GenePix image
analysis software (version 3.0.6.89, Axon Instruments, CA,
USA). The mean intensity of duplicate spots was analysed
using the linear range of the individual slide standard
micro-array [14].
Brain antigen preparation, gel electrophoresis,
immunoblotting, and data treatment
The PANAMA-Blot method was used to determine the
antibody repertoire to brain antigens as previously
described [15,16]. PANAMA-Blot is a powerful approach
allowing the analysis of the self-reactive antibodies
repertoire against a large panel of antigens. Briefly,
proteins from normal human brain, from a volunteer
donor after death, were separated on 10% SDS-PAGE at
25 mA, and were transferred onto nitrocellulose mem-
branes (Schleicher & Schull, Dassel, Germany) by semi-dry
electrotransfer (Pasteur Institute, Paris) for 1 h at 0.8 mA/
cm2. Membranes were blocked by incubation overnight at
room temperature with 0.2% Tween 20 in PBS (PBST), and
were then incubated with plasma samples diluted 1:20 in
PBST (non-adjusted assay), or at a total IgG concentration
of 200 μg/ml (adjusted assay), in a Cassette Miniblot
System (Immunetics, MA, USA). Membranes were
incubated for 4 h at room temperature with gentle
shaking. Bound IgG were detected with rabbit anti-
human IgG–alkaline phosphatase (Sigma-Aldrich,
France) and nitroblue tetrazolium/5-bromo-4-chloro-
3-indolyl-phosphate (Promega, France) incubated for
90 minutes at room temperature. Immunoreactivity
was detected with NBT/BCPI (nitroblue tetrazolium/
5-bromo-4-chloro-3-indolyl-phosphate) and the quantita-
tive signals were normalized using the IGOR 3.16 software
(Wavemetrics, Lake Oswego, OR, USA). A standard plasma
sample (a mixture of diverse plasma samples from
Gabonese individuals diluted 1:20) was applied in duplicate
for intensity adjustment.
Statistical analysis
Immunoblot data were analysed by multivariate statistical
methods, using IGOR software (Wavemetrics, Lake
Oswego, OR, USA). After baseline subtraction, the
standard migration scale was divided into sections
around individual peaks of immunoreactivity. Section-wise
absorbance values were subjected to principal component
analysis (PCA). The first component (PCA-1) was the
one-dimensional fitting vector that accounted for the
largest proportion of variance and factor 2 (PCA-2) was
the second-best orthogonal one-dimensional vector fitting
the data. Quantitative comparisons between groups were
done either with the Mann–Whitney (between two
groups) or Kruskal-Wallis tests (>two groups). Qualitative
association was tested by Pearson’s c2 test. The association
between continuous quantitative parameters was assessed
Guiyedi et al. Malaria Journal  (2015) 14:162 Page 4 of 11by Spearman’s rank correlation. The trend over time was
tested by the paired t-test; p-values <0.05 were considered
significant. Linear discriminant analysis was performed on
log-transformed data, and samples with incomplete
information were rejected. The significance of contributing
parameters was calculated by backward elimination, using
partial F tests on variances explained by models with or
without the respective parameters. The significance
criterion was a Bonferroni-corrected p-value <0.05.
Single linkage hierarchical clustering of the antibody
response against the 20 P. falciparum antigens tested
in the different groups was performed using the
hclust function in R software. For the heatmaps, fold
change of the antibody response and was calculated
using the formula Fc = μ1/μ2 for μ1 > μ2 and Fc = −μ2/μ1
for μ1 < μ2, where μ1 is the mean of the first group and
μ2 the mean of the second group compared. The same
methods were used for brain self-reactive IgG responses
clustering and heatmaps.Results
Distribution of total and Plasmodium falciparum-specific
IgG in EC, AM and MM groups
Three groups of patients were studied: 18 in EC, 22 in
AM, and 57 in MM. Sex distribution and mean age were
not significantly different in the three groups (Table 1).
The median parasitaemia was significantly lower in AM
than in MM (0.11% (range 0.01 − 1.2) versus 4.5% (range
0.6 − 48.6); p <0.001), (Figure 1A). Total IgG levels at
day 0 (hospitalisation day) before treatment were not
significantly different in the three groups (Table 1).
There was no correlation between parasite load and total
IgG levels. However, a significant increase with age of
total IgG concentrations was observed at day 0 (Spearman
R = 0.23, p = 0.01), regardless of group (Figure 1B).
Levels of P. falciparum-specific IgG in the three groups
were also statistically indistinguishable (Figure 1C). It
is noteworthy that 49% of patients in MM group had
highest levels of anti-P. falciparum IgG at day 0
(levels >3 pg/ml), compared to 17% in AM and 11%
in EC (overall c2 = 6.7, p = 0.03), (Figure 1D). There
was no correlation between P. falciparum-specific IgG
levels and parasite loads.Table 1 General characteristics of patients in the different cli
Group Patient no. (%) Mean age (range) Sex
EC 18 (18.56) 2.6 (0.5 – 5) 10/8
AM 22 (22.68) 2.8 (0.1 – 5) 12/1
MM 57 (58.76) 3 (0.5 – 6) 20/3
Total 97 (100) 2.8 (0.1 – 6) 42/4
EC: uninfected controls, AM: asymptomatic P. falciparum-infected patients, MM: Mild
*Not determined for 7 patients.
Levels of total Immunoglobulin G were quantified in all groups on day of inclusionSerological evaluation of the repertoire of Plasmodium
falciparum-specific IgG in AM and MM patients
The repertoires of parasite antigens recognized by EC,
AM and MM were compared using a protein micro-
array consisting of 20 antigens, including 13 variants of
MSP1, MSP2 and MSP3 from P. falciparum 3D7 and
FC27 clones, AMA1, PfEMP1, and NANP-4. The results
showed that 80% of the studied population, including
EC, recognized at least one of the P. falciparum antigens
tested while 20% had any reactivity (Figure 2A). In
addition, 75% of MM recognized the highest number of
P. falciparum antigens when compared to 15% in AM
and 10% in EC. When grouped together, 60% of the studied
population had IgG to MSP2, 75% IgG to MSP1-19 IgG
and less than 40% had IgG to at least one the other tested
antigens (Figure 2B). It is worthy to note that no
reactivity was observed against AMA1, PfEMP1, GST
and NANP-4. The most significant difference between
the groups was observed by Kruskal-Wallis for MSP3-3D7
(Figure 2C; p = 0.034). Plasma levels (pg/mL) of circulating
anti-MSP3-3D7 IgG was higher in the AM group than in
the MM and EC groups (Figure 2D; p = 0.03). It is also
noteworthy that 55% of AM compared to 12% EN and
19% MM produced IgG anti-MSP3-3D7. Conversely, the
level of anti-MSP1-19 antibody was significantly higher in
the MM than in AM and EC [see Additional file 1]. In the
same patient group, IgG to MSP2-3D7 or MSP2-FC27
detected in some MM patients on day 0 persisted
with the same intensity until day 30, even after treatment
[see Additional file 2A]. However, for some of the antigens,
such as MSP1-19, reactivity increased between days 0 and
7 or between days 0 and 30 [see Additional file 2B].
Single linkage hierarchical clustering was then applied to
compare the repertoire of antigenic specificities recognized
by circulating IgG of P. falciparum infected individuals at
day 0 before the start of drug therapy as well as for EC.
Interestingly, AM and MM groups typically recognized
MSP2 and children in AM group showed a predominant
IgG response against two MSP2 variants (FC 27 and
MSP2-3D7) compared to the EC group, whereas IgG to
MSP1-B2 PAR distinguished MM from AM (Figure 2E). By
contrast, the EC group showed a predominant response to
MSP1-19 GST (Figure 2E) and to anti- Myelin Basic
Protein (MBP) used as an irrelevant antigen (Figure 2F).nical groups
ratio (M/F) Mortality Total IgG mean in mg/ml (SD)
0 18.5 (13.0)
0 0 23.8 (22.8)
0* 0 13.5 (7.6)
8 0 17.02 (14.3)
Malaria, SD: standard deviation.
in the study and before treatment for MM patients (corresponding to day 0).
Figure 1 Epidemiological and serological characteristics of the study population. (A) Parasite loads (percentage of P. falciparum-infected red
blood cells) in the EC, AM and MM groups. (B) Correlation between total IgGs and age of the children in EC, AM and MM groups. (C) Levels of
IgG recognizing total P. falciparum antigens in the EC, AM and MM groups. (D) Proportion of patients with >3 pg/ml of P. falciparum-specific IgG
in the respective clinical groups.
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IgG response between groups were also assessed
using an unpaired t-test. AM individuals produced
significantly greater anti-MSP3 IgG than EC individ-
uals, whereas anti-MSP1 IgG was predominant in
MM patients (Figure 2F). These data show that MSP1
from P. falciparum 3D7 strain are recognized by the IgG
of patients with disease (MM), whereas MSP3 and MSP2
antigens are predominantly recognized by IgG of AM
carriers.
Profiles of self-reactive IgG to brain antigens in EC,
AM and MM groups
The self-reactive response induced by P. falciparum
infection was investigated by measuring auto-antibodies
against against brain protein extract using a quantitative
immunoblots. Differential repertoire analysis was done on
all groups using Principal Component Analysis (PCA).
PCA-1 represents a score of total anti-brain activity. Both
in non-adjusted and adjusted assays, PCA-1 was higher in
the AM group than in MM and EC groups, particularly in
patients older than 18 months in whom the presence of
maternal IgG could be excluded (Figure 3A). Anti-brain
reactivity (PCA-1 score) was also significantly correlated
with age (Spearman R = +0.45, p <0.001) (Figure 3B) and
total plasma IgG concentration (Spearman R = +0.38,p <0.001) (Figure 3C) in all groups. However, there was
no relationship between the reactivity profile and sex of
the individual or parasitaemia. The overall number of
brain antigens (bands) recognized by plasma IgG was
not different among the three groups. Single linkage
hierarchical clustering allowed to detect two clusters
of self-antigens (section 0–5, corresponding to high
molecular weight antigens, and section 25–29, with
relatively low molecular weight which were recognized by
almost all individuals in the study (see Additional file 3).
However, because of the high variability, no particular
signature of reactivity could be identified in AM and
MM patients, either by clustering or by fold change
comparison (see Additional file 4).
Relationship between self-reactive and Plasmodium
falciparum-specific antibody responses
The subjects were grouped according to anti-brain
(PCA-1 score > +1.5) and anti-P. falciparum (>3 pg/mL)
IgG reactivity. With the exception of two, all study partici-
pants fell into three sub-groups: α) high self-reactive IgG
and low P. falciparum-specific IgG; β) low self-reactive IgG
and high P. falciparum-specific IgG; and, δ) low self-
reactive IgG and low P. falciparum-specific IgG (Figure 4A).
Participants were unequally distributed between sub-
groups. AM individuals were over-represented in sub-
Figure 2 Repertoire of Plasmodium falciparum antigenic diversity recognized by infected children in Gabon. (A) Percentage of individuals in the
study population that recognized at least one P. falciparum antigen. (B) Antibody patterns and percentage of positive patients for each of the 20
P. falciparum-specific antigens tested in the total study population. (C) Kruskal-Wallis analysis of the antibody responses against the 20 parasite
antigens in all groups. (D) Plasma levels (pg/mL) of anti-P. falciparum MSP3-3D7 antibodies in EC, AM and MM. (E) Single linkage hierarchical clustering of
the antibody response against the 20 P. falciparum antigens tested in the different groups. (F) Heat map representing fold change of the
antibody response and Mann–Whitney p-value comparing the different groups: AM vs MM, AM vs EC, and EC vs MM. Antigens: MSP1 block
2 PA repeats; MSP1 block 2 3D7 Wellcome repeats; MSP1 block 2 3D7 full length; MSP1 block 2 3D7 Wellcome full length; MSP1 block 2
MAD20 full length; MSP1 block 2 RO33 full length; MSP1 block 2 K1 super repeats; MSP1 block 2 K1 flanking; MSP1 block 2 MAD20 repeats;
MSP1 block 2 3D7 repeats; MSP3 3D7; MBP; MSP3 K1; MSP2 3D7; MSP2 FC27; AMA-1; GST; MSP1-19 GST; PfEMP1; NANP.
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Figure 3 Patterns of brain self-reactive IgG responses in EC, AM and MM groups. PCA-1 scores for (A) the different groups, (B) relation to age,
and (C) relation to total plasma IgGs.
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p = 0.0004) (Figure 4B). Conversely, sub-group β con-
tained more MM (33% MM versus 10% AM and 6%
EC, χ2 = 7.4; p = 0.02) (Figure 4B). Most EC children
were classified into sub-group δ. These data clearly
suggest that AM is associated with a predominant
self-antibody response against brain antigens and low
parasite-specific IgG while MM is associated with
low self-reactive antibodies but high parasite-specific
response.
Cytokines associated with Plasmodium falciparum-specific
and self-reactive antibody responses in AM and MM groups
Levels in plasma of IFN-γ, TNF and IL-10 were assessed
in all children. Plasma concentrations of IFN-g-γ were
similar in the three groups (Figure 5A), whereas TNF
levels were significantly lower in MM than EC or AM
(p = 0.001 and 0.01, respectively) (Figure 5B). In contrast,
IL-10 levels were significantly increased during infection
in AM and MM groups (p = 0.03 and p < 0.001, respect-
ively; Figure 5C). IL-10 concentrations was significantly
correlated with parasite load on day 0 in infected chil-
dren (R-Spearman = +0.71; p < 0.001) (Figure 5D) and
decreased significantly at day 7 in MM patients after
treatment with anti-malarial drugs (p = 0.007, paired t-test),
when no parasites were detectable in peripheral blood(see Additional file 5). However, there was no correlation
between cytokine responses and age.
To get an insight into networks involved in protective
mechanisms against clinical disease in asymptomatic
carriers, the association between cytokine profiles with
self-reactive and/or anti-P. falciparum IgG responses
were analysed using spearman correlation. Interestingly,
IgG to brain proteins were significantly correlated with
IL-10 levels in AM children over 18 months (Spearman
R = +0.92, p = 0.009) (Figure 6A). The same trend was
also observed for IFN-γ (Spearman R = +0.73, p = 0.03)
(Figure 6B). In addition, IL-10 concentrations signifi-
cantly correlated with parasite load on day 0 especially
in P. falciparum infected patients (R-Spearman = +0.71;
p < 0.001) (Figure 6C).
Discussion
An infinitesimally small fraction of antibodies produced
during P. falciparum infection recognize parasite anti-
gens; the rest are against unrelated or host antigens
[10,19]. To get an insight into the role played by these
auto-antibody in asymptomatic malaria, the relationship
between parasite-specific antibody responses and the
self-reactive repertoire was investigated in children with
uncomplicated malaria and in controls from an endemic
area of Libreville, Gabon. In addition, the plasma cytokine
Figure 4 Relationship between auto-antibody response and Plasmodium falciparum-specific antibody response. (A) Relationship of the auto-antibody
response to anti-P. falciparum IgG response in the EC, AM and MM groups, and division of response patterns into three sub-groups: α (anti-P. falciparum
IgG <3 pg/ml; F1 > 1.5), β (anti-falciparum IgG >3 pg/ml; F1 < 1.5), δ anti-falciparum IgG <3 pg/ml; F1 < 1.5). (B) Frequencies of patients in
α and β sub-groups in the EC, AM and MM groups.
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ations between such profiles and antibody responses.
Unlike previous studies that assessed the protective
role of auto-antibodies in malaria using a few antigens,
the self-reactivity repertoire in the three groups of patients
was evaluated using an approach that allowed the analysis
of a large number of antigens [16,17].
Surprisingly, the asymptomatic carriers displayed greater
self-reactive IgG response than MM children. The auto-
antibody response was correlated with age and total IgG
levels, suggesting a link with premunition [2,11,12]. These
findings corroborate previous studies demonstrating a highIgG self-reactivity to brain antigens in asymptomatic P.
falciparum and Plasmodium vivax patients [16]. However,
levels of P. falciparum-specific antibodies were lower in
AM than in MM. Antibody responses to MSP1-19 and
MSP1-B2 PAR antigens were predominant in MM, whereas
AM was associated with low levels of antibody to MSP1-19
but higher levels of antibodies to MSP3 and MSP2. These
observations suggest that parasite control does not depend
upon anti-P. falciparum antibody levels but is linked to the
nature and effector functions of those antibodies – such as
cytophilic antibodies – that contribute to parasite elimin-
ation [13-22]. Antigens expressed by merozoites during
Figure 5 Cytokines levels in respect to clinical status. Plasma levels of IFN-γ (A) TNF (B) and IL-10 (C) in the EC, AM and MM groups at the day of
hospitalization and before treatment.
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antibodies. Indeed, the IgG1 and IgG3 sub-classes have
been shown to play a role in anti-merozoite responses
[23,24]. Children in areas of high P. falciparum transmis-
sion are known to develop a strong antibody response to
PfEMP1 [25,26]. However, in this study, the anti-PfEMP1
antibody response was weak and did not correlate with re-
duced risk of clinical disease. This discrepancy could result
from genetic differences among the studied populations.
A correlation between elevated self-reactivity to brain
antigens and plasma levels of IFN-γ and IL-10 was
observed in the AM group. IL-10 is an anti-inflammatory
cytokine with a controversial role in malaria; high concen-
trations of IL-10 are associated with both severe disease
and protection [18,27]. In addition, plasmatic levels of
IL-10 correlated positively with parasite load and decreased
dramatically within a week of amodiaquine treatment,
concomitant to the disappearance of the parasite from
peripheral blood as reported [28,29]. Together, these
observations strongly suggest that in AM children,
clinical protection to malaria is associated with an increased
of self-reactive response, low levels of P. falciparum-specific
IgG, high plasma levels of IFN-γ and IL-10, while
MM was associated with high levels of IL-10 and specific
anti-falciparum antibodies but low self-reactive response
with low TNF secretion.There was no correlation between parasite-specific and
self-reactive antibody responses in the infected groups.
However, a self-antigen candidate was detected in the AM
group. This suggests that the self-reactive response during
P. falciparum infection may not be exclusively attributable
to cross-reactivity between parasite and host antigens or to
polyclonal B cell activation. The origin of the self-reactive
antibodies induced during malaria remains unclear.
Auto-antibodies associated with AM might be derived
from CD27+ marginal zone B cells that are expanded
in some auto-immune diseases. Alternatively, some of
these auto-antibodies could be ‘natural antibodies’ that
are produced in the absence of exogenous antigenic
stimulation and that are characterized by low affinity for
the antigen and polyreactivity [8,10,23]. Auto-antibodies
may participate in protective mechanisms by favouring
parasite clearance, which could explain the association of
a high self-reactive response and with low parasitaemia
(<1%) observed in AM [21-24]. Indeed, this has been pro-
posed as a mechanism of haemoglobinopathy-associated
protection against malaria [29-36].
Conclusions
The findings of a strong correlation between autoreactivity
and plasma cytokine profile, low P. falciparum-specific
IgG levels and low parasitaemia in AM children
Figure 6 Interaction between cytokine response and auto-antibody patterns. Correlation between self-reactivity (PCA-1 score) and (A) IL-10
plasma levels or (B) IFN-g plasma levels in AM patients older than 18 months. (C) Correlation between IL-10 plasma concentrations and parasite
loads at the day of hospitalization and before treatment.
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AM. They also strongly suggest a role for the auto-
antibody response in protective mechanisms against
clinical disease in P. falciparum-infected individuals
living in endemic areas.
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